中国药房

China Pharmacy (bimonthly) is a national-level, open-access academic journal of pharmacy, founded in 1990, under the supervision of the National Health and Health Commission, and jointly sponsored by the China Hospital Association and the Affiliated Cancer Hospital of Chongqing University, with the aim of ‘navigating the medical and health care’. It has a wide influence in the industry. It was founded in 1990, and its readers are mainly professional and technical personnel of all levels and types working in the pharmacy department of hospitals, as well as personnel in drug development, production, operation, clinical application and supervision and management. The main columns include: Guidelines and Consensus (including industry guidelines, consensus, norms and related interpretations, etc.), Pharmaceutical Management (including research on pharmaceutical and health policies, management of hospital pharmacy departments, and management of social pharmacies/pharmacies, etc.), Pharmacy Research (including basic research on pharmacology, pharmacy, and drug analysis, etc.), Pharmacoeconomics (including economic evaluations of medicines, and studies related to health insurance payments, etc.), Drugs and Clinics (including studies on drug regimens, blood drug regimens, and clinical applications), and Drugs and Clinics ( Drugs and Clinics (including research on drug treatment protocols, blood concentration testing, clinical pharmacological studies, adverse reactions, etc.), Evidence-Based Pharmacy (including evaluation of clinical medication systems, evidence-based research, etc.), Pharmacists and Pharmacy Services (including research on hospital pharmacy service models, medication data analysis, prescription review, medication monitoring, community pharmacy, pharmacist talent management, etc.), and reviews. Index： China Pharmacy is one of the ‘Chinese Core Journals’, ‘China Science and Technology Core Journals’, ‘China Journal Square Double Effect Journal’, ‘RCCSE China Authoritative Academic Journals’, “China Academic Journal Impact Factor Annual Report”, and “National Open Platform for Science and Technology Journals”. From 2009 to 2014, it has been listed in ‘China Science Citation Database (CSCD) Source Journals’, ‘Chinese Biomedical Journal Literature Database (CMCC)’, ‘Chinese Biomedical Journal Literature Database’ and ‘Chinese Biomedical Journal Literature Database’. ‘Chinese Biomedical Journal Citation Database (CMCI), Chinese Journal Full Text Database (CJFD), Chinese Biomedical Literature Retrieval and Analysis System CD-ROM Database (CBMdisc). ‘‘World Impact Index of Scientific and Technical Journals (WJCI) Report (2021 Science and Technology Edition)’’ “Scopus” ’American Chemical Abstracts (CA) ‘‘Abstracts Journal (AJ), Russia’‘ “International Pharmaceutical Abstracts (IPA), USA”’ ‘WHO Western Pacific Region Index of Medicine (WPRIM) ‘‘Ullrich's Periodical Directory (UPD)’’, “Japan Science and Technology Agency Database (JST)” and other important domestic and international databases.

《中国药房》杂志是国家卫生健康委员会主管、中国医院协会和重庆大学附属肿瘤医院联合主办的国家级、国内外公开发行的药学综合类学术刊物。读者对象主要为在医院药学部（药剂科）工作的各级各类专业技术人员，以及药品研制、生产、经营、临床应用及监督管理人员。创刊时间：1990年，出版周期：半月刊，全彩印刷。主要栏目包括：指南与共识（包括行业指南、共识、规范及相关解读等）、药事管理（包括医药卫生政策研究、医院药学部门管理、社会药房/药店管理等）、药学研究（包括药理学、药剂学、药物分析等基础研究）、药物经济学（包括药品的经济学评价、医保支付相关研究等）、药物与临床（包括药物治疗方案研究、血药浓度检测、临床药理研究、不良反应等）、循证药学（包括临床用药系统评价、循证研究等）、药师与药学服务（包括医院药学服务模式研究、用药数据分析、处方点评、用药监护、社区药学、药师人才队伍管理等）、综述等。